InMed CFO Bruce Colwill retiring; Brenda Edwards named interim CFO

InMed Pharmaceuticals Inc.

Bruce Colwill steps down as CFO effective March 31, 2022; will remain advisor through June 30, 2022.
Brenda Edwards appointed interim CFO effective April 1, 2022; over 35 years of experience including 20+ years as CFO.
Company has initiated a search for a permanent CFO replacement.
Ms. Edwards engaged through a placement agency at CAD$210/hour.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Brenda Edwards

Interim Chief Financial Officer

INM · InMed Pharmaceuticals Inc.

Effective: 2022-04-01
Filed: March 18, 2022, 7:59 PM ET

The Company appointed Ms. Brenda Edwards as Interim Chief Financial Officer of the Company effective April 1, 2022.

Departed

Bruce Colwill

Chief Financial Officer

INM · InMed Pharmaceuticals Inc.

Effective: 2022-03-31
Successor: Brenda Edwards
Filed: March 18, 2022, 7:59 PM ET

Mr. Bruce Colwill, will be retiring and will be stepping down from his position at the Company effective March 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brenda Edwards was appointed as Interim Chief Financial Officer at InMed Pharmaceuticals Inc..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

The Company appointed Ms. Brenda Edwards as Interim Chief Financial Officer of the Company effective April 1, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce Colwill retired as Chief Financial Officer at InMed Pharmaceuticals Inc..

Action: retired
Role: Chief Financial Officer

Exact text from the filing

Mr. Bruce Colwill, will be retiring and will be stepping down from his position at the Company effective March 31, 2022.

View on SEC.gov

InMed Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-013457

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.